[
  {
    "criterion": "Provides a clear and concise answer that takes into account the patient's creatinine clearance and bleeding risk.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Incorrectly suggests a fixed dose of enoxaparin regardless of the patient's creatinine clearance.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Fails to provide any information about the patient's creatinine clearance and its impact on enoxaparin dosing.",
    "axis": "completeness",
    "point": -8
  },
  {
    "criterion": "Uses overly technical or complex language that may be difficult for non-medical professionals to understand.",
    "axis": "communication_quality",
    "point": -4
  },
  {
    "criterion": "Correctly explains the need to adjust enoxaparin dosing based on the patient's creatinine clearance, but does not provide specific guidance on the recommended dose.",
    "axis": "completeness",
    "point": 5
  },
  {
    "criterion": "Incorrectly states that enoxaparin is not recommended for patients with severe renal impairment.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Asks the user for clarification on their question or request for additional information before providing a response.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a response that is overly focused on the patient's bleeding risk and fails to consider the risk of thrombosis.",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Uses natural language and clear explanations to provide information about enoxaparin dosing in patients with severe renal impairment.",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Fails to provide any information about the potential risks or benefits of adjusting enoxaparin dosing in patients with severe renal impairment.",
    "axis": "completeness",
    "point": -4
  }
]